We are currently experiencing a service degradation affecting customer login on our eShop platform in China. Our teams are actively working to resolve the issue and restore full functionality as soon as possible. If you encounter login difficulties, we recommend retrying after a short while. We appreciate your patience and understanding.

FectoVIR®-AAV

Tech Support Documents
FectoVIR®-AAV
 

FectoVIR®-AAV is a novel generation of synthetic transfection reagent specifically developed for industrial scale production of recombinant AAV (rAAV) in both suspension and adherent HEK-293 derivative cell systems

Amount of Reagent
Item No.: 
101000004
*Custom/bulk order quotes are provided within 72 hours of request.
FectoVIR®-AAV
FectoVIR®-AAV

FectoVIR®-AAV is a novel generation of synthetic transfection reagent specifically developed for industrial scale production of recombinant AAV (rAAV) in both suspension and adherent HEK-293 derivative cell systems

Item No.:
101000004

Overview

Specifications

Choose your Transfection For Viral Vector Manufacturing

See more products

FectoVIR®-AAV transfection reagent guarantees higher rAAV titers, improves scalability for large scale production and de-risks manufacturing process with its availability at pharma GMP grade. FectoVIR®-AAV-GMP is manufactured under a validated and aseptic process in compliance with ICH Q7, GMP part II guidelines, the quality grade of reference for active pharmaceutical ingredients (API).

Key Benefits:

    Process Economics: High AAV productivity expands the number of doses per batch to reduce manufacturing costs.
    Industrial Scalability: Designed for large scale with low complexation volume, long complex stability, and high reproducibility.
    GMP Grade Availability: Validated Manufacturing process following ICH Q7 guidelines, provided with full regulatory documentation.
    Risks Mitigation: Both residual test and toxicity statement enable to mitigate risks and ensure patient safety.

Applications

  • Application
    rAAV (Adeno-Associated Virus) manufacturing using HEK-293 derivative cells 

Biological Information

  • Number of transfections
    1 L of FectoVIR®-AAV transfection reagent is sufficient to transfect on average 500 L of cell culture (using standard conditions) 

Compliance Information

  • GMP Compliance
    No
  • Product Documentation
    • Protocol 
    • Certificate of Analysis 
    • Certificate of origin 
    • Non-hazardous product statement

General Specifications

  • Amount of Reagent
    FectoVIR®-AAV 100 mL

Storage Conditions

  • Storage Conditions
    5 °C ± 3 °C